{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-1980-N-0036\" sorted by posted_date descending", "rows": [["FDA-1980-N-0036-0046", "FDA", "FDA-1980-N-0036", "FDA/DDM to Martha D. Smith", "Other", "ACK-Acknowledgement Letter", "2006-02-24T05:00:00Z", 2006, 2, null, null, "2008-12-05T14:31:11Z", null, 0, 0, "09000064805b94ae"], ["FDA-1980-N-0036-0045", "FDA", "FDA-1980-N-0036", "FDA/CDER to Willing Solutions, Inc.", "Other", "ACK-Acknowledgement Letter", "2006-02-23T05:00:00Z", 2006, 2, null, null, "2008-12-05T14:30:22Z", null, 0, 0, "09000064805b94ad"], ["FDA-1980-N-0036-0025", "FDA", "FDA-1980-N-0036", "Comparison of Cationic-Surfactant & Phenol-Based Mouthwash-Gargles In Relieving Oropharyngeal Pain", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:39:55Z", null, 0, 0, "09000064805b9499"], ["FDA-1980-N-0036-0036", "FDA", "FDA-1980-N-0036", "Coal Tar, Ultrviolet Light & Cancer", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T18:03:00Z", null, 0, 0, "09000064805b94a4"], ["FDA-1980-N-0036-0016", "FDA", "FDA-1980-N-0036", "Phenol & It's Derivatives: The Relation Between Their Chemical Constitution & Their Effect on The Organism", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T16:19:15Z", null, 0, 0, "09000064805b9490"], ["FDA-1980-N-0036-0043", "FDA", "FDA-1980-N-0036", "Skin Carcinoma In Patients With Psoriasis Treated With Topical Tar & Artificial Ultraviolet Radiation", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T18:13:08Z", null, 0, 0, "09000064805b94ab"], ["FDA-1980-N-0036-0042", "FDA", "FDA-1980-N-0036", "Gynaseptic In The Treatment of Vaginitis", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T18:11:31Z", null, 0, 0, "09000064805b94aa"], ["FDA-1980-N-0036-0039", "FDA", "FDA-1980-N-0036", "Structure of Povidone-Iodine", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T18:06:47Z", null, 0, 0, "09000064805b94a7"], ["FDA-1980-N-0036-0028", "FDA", "FDA-1980-N-0036", "Combined Steroid Antiinfective Topical Therapy In Common Dermatoses: A Double-Blind, Multi-Center Study of Iodochlorhydroxyquin-Hydrocortisone In 277 Patients", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:47:21Z", null, 0, 0, "09000064805b949c"], ["FDA-1980-N-0036-0019", "FDA", "FDA-1980-N-0036", "Memorandum", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:27:16Z", null, 0, 0, "09000064805b9493"], ["FDA-1980-N-0036-0021", "FDA", "FDA-1980-N-0036", "Antimicrobial II Panel-27th Meeting-June 24th through 26th, 1977", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:31:26Z", null, 0, 0, "09000064805b9495"], ["FDA-1980-N-0036-0015", "FDA", "FDA-1980-N-0036", "Percutaneous Absorption & Disposition of Iodochlorhydroxyquin In Dogs", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T16:17:13Z", null, 0, 0, "09000064805b948f"], ["FDA-1980-N-0036-0044", "FDA", "FDA-1980-N-0036", "Percutaneous Absporption of Iodochlorhydroxyquin In Humans", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T18:14:53Z", null, 0, 0, "09000064805b94ac"], ["FDA-1980-N-0036-0041", "FDA", "FDA-1980-N-0036", "Tolnaftate Powder In Prophylaxis of Tinea Pedis", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T18:10:08Z", null, 0, 0, "09000064805b94a9"], ["FDA-1980-N-0036-0034", "FDA", "FDA-1980-N-0036", "Introductory Review of Subacute Myelo-Optico-Neuropathy (S. M. O. N.) & It's Studies Done By The S. M. O. N. Research Commission", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:59:14Z", null, 0, 0, "09000064805b94a2"], ["FDA-1980-N-0036-0026", "FDA", "FDA-1980-N-0036", "An Epidemic of Infection with Trichophyton Tonsurans Revealed In A 20-Year Survey of Fungal Infections In Chicago", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:43:30Z", null, 0, 0, "09000064805b949a"], ["FDA-1980-N-0036-0017", "FDA", "FDA-1980-N-0036", "Sterile Clindamycin Phosphate", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T16:20:37Z", null, 0, 0, "09000064805b9491"], ["FDA-1980-N-0036-0023", "FDA", "FDA-1980-N-0036", "Clinical Evaluation of An Anesthetic Mouthwash", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:36:39Z", null, 0, 0, "09000064805b9497"], ["FDA-1980-N-0036-0024", "FDA", "FDA-1980-N-0036", "Evaluation of An Antiseptic Anesthetic Solution", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:37:42Z", null, 0, 0, "09000064805b9498"], ["FDA-1980-N-0036-0038", "FDA", "FDA-1980-N-0036", "Evaluation of Chloraseptic Solution As An Anesthetic Mouthwash", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T18:05:36Z", null, 0, 0, "09000064805b94a6"], ["FDA-1980-N-0036-0035", "FDA", "FDA-1980-N-0036", "Incidence of Skin Cancers In Patients with Atopic Dermatitis Treated With Coal Tar: A 25-Year Follow-Up Study", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T18:01:08Z", null, 0, 0, "09000064805b94a3"], ["FDA-1980-N-0036-0020", "FDA", "FDA-1980-N-0036", "Correspondence & Memorandums", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:29:18Z", null, 0, 0, "09000064805b9494"], ["FDA-1980-N-0036-0030", "FDA", "FDA-1980-N-0036", "Dermatologic Drugs Advisory Committee-26th Meeting-November 18, 1985", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:51:21Z", null, 0, 0, "09000064805b949e"], ["FDA-1980-N-0036-0018", "FDA", "FDA-1980-N-0036", "Chloraderm In Tinca Pedis", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:25:51Z", null, 0, 0, "09000064805b9492"], ["FDA-1980-N-0036-0022", "FDA", "FDA-1980-N-0036", "Clinical Evaluation of A New Halcinonide-Antifungal Combination", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:35:34Z", null, 0, 0, "09000064805b9496"], ["FDA-1980-N-0036-0040", "FDA", "FDA-1980-N-0036", "Zur Kenntinis der antimikrobiellen Aktivitat von Breitspektrum-Antimikrobika unter besonderer Berucksichtigung der Salicylsaure", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T18:08:44Z", null, 0, 0, "09000064805b94a8"], ["FDA-1980-N-0036-0033", "FDA", "FDA-1980-N-0036", "Evaluation of Chloraderm As A Dermtologic Agent: A Study of Bacteriologic, Fungicidal & Antipuritic Properties", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:56:53Z", null, 0, 0, "09000064805b94a1"], ["FDA-1980-N-0036-0031", "FDA", "FDA-1980-N-0036", "Cited References", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:52:41Z", null, 0, 0, "09000064805b949f"], ["FDA-1980-N-0036-0027", "FDA", "FDA-1980-N-0036", "Prophylaxis of Tinea Pedis: Efficacy of Tolnaftate Powder & It's Talc-Constarch Base", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:44:59Z", null, 0, 0, "09000064805b949b"], ["FDA-1980-N-0036-0029", "FDA", "FDA-1980-N-0036", "Tolnaftate As A Prophylactic Agent for Tinea Pedis", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:49:58Z", null, 0, 0, "09000064805b949d"], ["FDA-1980-N-0036-0037", "FDA", "FDA-1980-N-0036", "Evaluation of Chloraseptic", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T18:04:12Z", null, 0, 0, "09000064805b94a5"], ["FDA-1980-N-0036-0032", "FDA", "FDA-1980-N-0036", "Evaluation of Chloraderm In The Topical Therapy of \"Athlete's Foot\"", "Supporting & Related Material", "BKG-Background Material", "2006-02-21T05:00:00Z", 2006, 2, null, null, "2008-12-08T17:55:02Z", null, 0, 0, "09000064805b94a0"], ["FDA-1980-N-0036-0012", "FDA", "FDA-1980-N-0036", "FDA/Office of the Commissioner to The Purdue Fredrick Company", "Other", "LET-Letter", "2002-05-31T04:00:00Z", 2002, 5, null, null, "2008-12-05T14:27:46Z", null, 0, 0, "09000064805b948c"], ["FDA-1980-N-0036-0011", "FDA", "FDA-1980-N-0036", "Nonprecription Drugs Advisory Committee-April 15, 1997 Transcript", "Other", "TR-Transcript", "1997-09-22T04:00:00Z", 1997, 9, null, null, "2012-10-04T19:34:01Z", null, 0, 0, "09000064805b9489"]], "truncated": false, "filtered_table_rows_count": 34, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-1980-N-0036"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1980-N-0036", "results": [{"value": "FDA", "label": "FDA", "count": 34, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0036&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1980-N-0036", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 30, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0036&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0036&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1980-N-0036", "results": [{"value": 2006, "label": 2006, "count": 32, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0036&posted_year=2006", "selected": false}, {"value": 1997, "label": 1997, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0036&posted_year=1997", "selected": false}, {"value": 2002, "label": 2002, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0036&posted_year=2002", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0036&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0036&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0036&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0036&_facet_date=posted_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0036&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 9834.32323904708, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}